Antimycobacterial activity of 2-methyl-adenosine

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 5, 2003, Pages 801-808

  Barrow, Esther W ^a   Westbrook, Louise ^b   Bansal, Namita ^b   Suling, William J ^b   Maddry, Joseph A ^b   Parker, William B ^b   Barrow, William W ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

MICs; Mycobacterium nucleoside analogues

Indexed keywords

2 METHYLADENOSINE; ANTIMYCOBACTERIAL AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BACTERIAL RNA; OFLOXACIN; PURINE DERIVATIVE; RADIOISOTOPE; RIFAMPICIN; STREPTOMYCIN SULFATE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BIOASSAY; BIOLOGICAL MODEL; CELL HYPOXIA; CELL LINE; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; DILUTION; DNA SYNTHESIS; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; MACROMOLECULE; MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRECURSOR; PROTEIN SYNTHESIS; PURINE METABOLISM; RNA SYNTHESIS; TUBERCULOSIS;

ADENOSINE; BACTERIAL PROTEINS; CELL LINE; COLONY COUNT, MICROBIAL; DNA, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; RNA, BACTERIAL; VIRUS LATENCY;

EID: 0242437859     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg444     Document Type: Article

References (32)

1. Zhang, Y. & Telenti, A. (2000). Genetics of drug resistance in Mycobacterium tuberculosis. In Molecular Genetics of Mycobacteria (Hatfull, G. F. & Jacobs, J. W. R., Eds), pp. 235-54. ASM Press, Washington, DC, USA.
2. Suhadolnik, R. J. (1970). Nucleoside Antibiotics. John Wiley & Sons, Inc., New York, NY, USA.
3. Chen, C.-K., Barrow, E. W., Allan, P. W. et al. (2002). Biochemical and genetic characterization of the metabolism of 2-methyl-adenosine in Mycobacterium smegmatis. Microbiology 148, 289-95.
4. Barrow, E. L. W., Winchester, G. A., Staas, J. K. et al. (1998). Use of microsphere technology for sustained and targeted delivery of rifampicin to Mycobacterium tuberculosis-infected macrophages. Antimicrobial Agents and Chemotherapy 42, 2682-9.
5. Tomioka, H., Sato, K., Kajitani, H. et al. (2000). Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrobial Agents and Chemotherapy 44, 283-6.
6. Wright, E. L., Quenelle, D. C., Suling, W. J. et al. (1996). Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies. Antimicrobial Agents and Chemotherapy 40, 2206-8.
7. Wayne, L. G. (1976). Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. American Review of Respiratory Diseases 114, 807-11.
8. Wayne, L. G. (1977). Synchronized replication of Mycobacterium tuberculosis. Infection and Immunity 17, 528-30.
9. Wayne, L. G. & Lin, K. Y. (1982). Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infection and Immunity 37, 1042-9.
10. Wayne, L. G. & Sramek, H. A. (1994). Metronidazole is bactericidal to dormant cells of Mycobacterium, tuberculosis. Antimicrobial Agents and Chemotherapy 38, 2054-8.
11. Wayne, L. & Hayes, L. G. (1996). An in vitro model for sequential study of downshift of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infection and Immunity 64, 2062-9.
12. Suling, W. J., Reynolds, R. C., Barrow, E. W. et al. (1998). Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase. Journal of Antimicrobial Chemotherapy 42, 811-5.
13. Suling, W. J., Seitz, L. E., Pathak, V. et al. (2000). Antimycobacterial activity of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase (DHFR). Antimicrobial Agents and Chemotherapy 44, 2784-93.
14. Yajko, D. M., Madej, J. J., Lancaster, M. V. et al. (1995). Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. Journal of Clinical Microbiology 33, 2324-7.
15. Collins, L. A. & Franzblau, S. G. (1997). Microplate Alamar Blue assay versus BACTEC 460 System for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrobial Agents and Chemotherapy 41, 1004-9.
16. Ziegler-Heitbrock, H. W. L., Thiel, E., Fütterer, A. et al. (1988). Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. International Journal of Cancer 41, 456-61.
17. Harshey, R. M. & Ramakrishnan, T. (1977). Rate of ribonucleic acid chain growth in Mycobacterium tuberculosis H37Rv. Journal of Bacteriology 129, 616-22.
18. Hiriyanna, K. T. & Ramakrishnan, T. (1986). DNA replication time in Mycobacterium tuberculosis H37Rv. Archives of Microbiology 144, 105-9.
19. Shaila, M. S., Gopinathan, K. P. & Ramakrishnan, T. (11973). Protein synthesis in Mycobacterium tuberculosis H37Rv and the effect of streptomycin in streptomycin-susceptible and -resistant strains. Antimicrobial Agents and Chemotherapy 4, 205-13.
20. Singh, M. P., Petersen, P. J., Weiss, W. J. et al. (2000). Saccharomicins, novel heptadecaglycoside antibiotics produced by Saccharothrix espanaensis: antibacterial and mechanistic activities. Antimicrobial Agents and Chemotherapy 44, 2154-9.
21. Singh, M. P., Petersen, P. J., Weiss, W. J. et al. (2003). Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities. Antimicrobial Agents and Chemotherapy 47, 62-9.
22. Kennell, D. (1967). Use of filters to separate radioactivity in RNA, DNA, and protein. Methods in Enzymology 12a, 686-92.
23. Wayne, L. G. (2001). In vitro model of hypoxically induced nonreplicating persistence of Mycobacterium tuberculosis. In Mycobacterium tuberculosis Protocols (Parish, T. & Stoker, N. G., Eds), pp. 247-69. Humana Press, Totowa, NJ, USA.
24. Bodmer, W. F. & Grether, S. (1965). Uptake and incorporation of thymine, thymidine, uracil, uridine, and 5-fluorouracil into the nucleic acids of Bacillus subtilis. Journal of Bacteriology 89, 1011-4.
25. Saito, H. & Tomika, H. (1984). Thymidine kinase of bacteria: activity of the enzyme in actinomycetes and related organisms. Journal of General Microbiology 130, 1863-70.
26. Boon, C., Li, R., Qi, R. et al. (2001). Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. Journal of Bacteriology 183, 2672-6.
27. Lim, A., Eleuterio, M., Hutter, B. et al. (1999). Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. Journal of Bacteriology 181, 2252-6.
28. Parker, W. B., Shaddix, S. C., Rose, L. M. et al. (2000). Metabolism of 4′-thio-β-D-arabinofuranosylcytosine in CEM cells. Biochemical Pharmacology 60, 1925-32.
29. Fernandez, R. O. & Anton, D. N. (1987). Bacteriostatic action of streptomycin on ribosomally resistant mutants (rpsL) of Salmonella typhimurium. Antimicrobial Agents and Chemotherapy 31, 1627-31.
30. Agou, F., Quevillon, S., Kerjan, P. et al. (1998). Switching the amino acid specificity of an aminoacyl-tRNA synthetase. Biochemistry 37, 11309-14.
31. Weaver, R. F. (2002). Molecular Biology. McGraw-Hill, Boston, MA, USA.
32. Snyder, L. & Champness, W. (1997). Molecular Genetics of Bacteria. ASM Press, Washington, DC, USA.